Documents

Ideas Discussions Technicals Forecast Seasonals Options

Arbutus Biopharma Corporation SEC filings and other documents

Explore the latest company documents and SEC filings from Arbutus Biopharma Corporation, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 06, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 14, 2025

Quarterly report10-Q

Earnings release8-K

2024

Q4 2024

Mar 27, 2025

Earnings release8-K

Annual report10-K

Q3 2024

Nov 06, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 01, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 02, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Feb 29, 2024

Annual report10-K

Earnings release8-K

Corporate Presentation

Nov 09, 2023

Slides

Q3 2023

Nov 07, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 03, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 04, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 02, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 09, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Aug 04, 2022

Quarterly report10-Q

Earnings release8-K

2021

Q4 2021

Mar 03, 2022

Annual report10-K

2020

Q4 2020

Mar 04, 2021

Annual report10-K

2019

Q4 2019

Mar 05, 2020

Annual report10-K

2018

Q4 2018

Mar 07, 2019

Annual report10-K

2017

Q4 2017

Mar 16, 2018

Annual report10-K

2016

Q4 2016

Mar 22, 2017

Annual report10-K

2015

Q4 2015

Mar 09, 2016

Annual report10-K

2014

Q4 2014

Mar 13, 2015

Annual report10-K